Document ID: chunk:federal_register_of_legislation:F2022C00911:front:0:p6
Version: federal_register_of_legislation:F2022C00911
Segment Type: other
Provision Reference: 
Character Range: 15380–18669

having hypertension before the clinical worsening of retinal vascular occlusion;
(25)      having diabetes mellitus before the clinical worsening of retinal vascular occlusion;
(26)      being obese for at least five years within the 15 years before the clinical worsening of retinal vascular occlusion;
            Note: being obese is defined in the Schedule 1 - Dictionary.
(27)      having dyslipidaemia before the clinical worsening of retinal vascular occlusion;
            Note: dyslipidaemia is defined in the Schedule 1 - Dictionary.
(28)      having hyperhomocysteinaemia before the clinical worsening of retinal vascular occlusion;
(29)      having an arteritis from the specified list of systemic arteritides, at the time of the clinical worsening of retinal vascular occlusion;
            Note: specified list of systemic arteritides is defined in the Schedule 1 - Dictionary.
(30)      having retinal vasculitis at the time of the clinical worsening of retinal vascular occlusion;
            Note: retinal vasculitis is defined in the Schedule 1 - Dictionary.
(31)      having a non-inflammatory vasculopathy of the cerebral or retinal vessels from the specified list of vasculopathies at the time of the clinical worsening of retinal vascular occlusion;
            Note: specified list of vasculopathies is defined in the Schedule 1 - Dictionary.
(32)      having a disorder that is associated with a hypercoagulable state or hyperviscosity at the time of the clinical worsening of retinal vascular occlusion;
Note: disorder that is associated with a hypercoagulable state or hyperviscosity is defined in the Schedule 1 - Dictionary.
(33)      having:
(a)          a benign or malignant neoplasm; or
(b)          a non-neoplastic mass lesion;
which compresses or infiltrates the retinal vessels of the affected eye at the time of the clinical worsening of retinal vascular occlusion;
             Note 1: Examples of a benign or malignant neoplasm include astrocytoma, optic nerve meningioma, leukaemia and lymphoma.
             Note 2: Examples of a non-neoplastic mass lesion include haematoma, sarcoidosis, neurofibromatosis and exophthalmos.
(34)      having a vascular abnormality of the retinal vessels of the affected eye at the time of the clinical worsening of retinal vascular occlusion;
Note: Examples of a vascular abnormality include arterio-venous malformation and prepapillary vascular loop.
(35)      having migraine at the time of the clinical worsening of retinal vascular occlusion;
(36)      having infection with human immunodeficiency virus before the clinical worsening of retinal vascular occlusion;
(37)      having an ocular or orbital infection involving the affected eye within the 30 days before the clinical worsening of retinal vascular occlusion;
            Note 1: Examples of an ocular or orbital infection include:
                (a) cat scratch disease;
                (b) herpes zoster ophthalmicus;
                (c) ocular tuberculosis; and
                (d) orbital abscess or cellulitis.
            Note 2: This excludes isolated conjunctivitis or blepharitis of the affected eye.
(38)      having direct external pressure to the eyeball of the affected eye for a continuous period of at least ten minutes, within the 24